Scholar Rock Holding (SRRK) Valuation Check After Mixed Short Term Share Performance

Simply Wall St.01-11

Scholar Rock Holding (SRRK) has drawn investor attention after recent share price moves, with the stock last closing at US$42.18. That price sits against a mixed return profile across the past month ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602534345?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-01-11 06:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602534345","market":"hk","top_or_hot":-1,"title":"Scholar Rock Holding (SRRK) Valuation Check After Mixed Short Term Share Performance","media":"Simply Wall St.","content":"<div>\n<p>Scholar Rock Holding (SRRK) has drawn investor attention after recent share price moves, with the stock last closing at US$42.18. That price sits against a mixed return profile across the past month ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-valuation-check-after-mixed-short\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Scholar Rock Holding (SRRK) Valuation Check After Mixed Short Term Share Performance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nScholar Rock Holding (SRRK) Valuation Check After Mixed Short Term Share Performance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-11 06:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-valuation-check-after-mixed-short><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Scholar Rock Holding (SRRK) has drawn investor attention after recent share price moves, with the stock last closing at US$42.18. That price sits against a mixed return profile across the past month ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-valuation-check-after-mixed-short\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SRRK","symbol_name":"Scholar Rock Holding Corp","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-valuation-check-after-mixed-short","article_id":"2602534345","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/scholar-rock-holding-srrk-valuation-check-after-mixed-short","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602534345","pubTimestamp":1768083732,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Scholar Rock Holding (SRRK) has drawn investor attention after recent share price moves, with the stock last closing at US$42.18. That price sits against a mixed return profile across the past month and the past 3 months.\nSee our latest analysis for Scholar Rock Holding.\nLooking past the recent pullback, Scholar Rock Holding’s 30 day share price return of a 6.37% decline contrasts with a 6.89% gain over 90 days. The 3 year total shareholder return of about 3.5x suggests momentum has broadly...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"SRRK":"Scholar Rock Holding Corp","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4139":"生物科技"},"translate_title":"Scholar Rock Holding(SRRK)短期股价表现好坏参半后的估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SRRK":1.5,"DCF":1},"content_text":"Scholar Rock Holding (SRRK) has drawn investor attention after recent share price moves, with the stock last closing at US$42.18. That price sits against a mixed return profile across the past month and the past 3 months. See our latest analysis for Scholar Rock Holding. Looking past the recent pullback, Scholar Rock Holding’s 30 day share price return of a 6.37% decline contrasts with a 6.89% gain over 90 days. The 3 year total shareholder return of about 3.5x suggests momentum has broadly been building over a longer horizon. If Scholar Rock’s recent move has you thinking about opportunities in the sector, this could be a good moment to widen your search across healthcare stocks. So, with the shares at US$42.18, a 30-day decline, a 90-day gain, and an intrinsic value estimate implying a wide discount, is this a genuine entry point, or is the market already pricing in future growth potential? AdvertisementPrice to Book of 17.6x: Is it justified? On P/B, Scholar Rock Holding trades at 17.6x against a last close of US$42.18, which screens as cheaper than its direct peers but far richer than the broader biotech group. P/B compares the company’s market value to its book value, which is the net assets on the balance sheet. For a pre revenue, loss making biopharma name like Scholar Rock, investors often look at P/B as a shorthand for what the market is willing to pay for its research pipeline and future potential beyond the current accounting equity. Here, Scholar Rock’s 17.6x P/B is flagged as good value versus its peer average of 24.8x, suggesting the market assigns a lower premium than to similar companies. At the same time, the same 17.6x stands far above the broader US biotech industry average of 2.7x, indicating a very rich valuation level compared with the sector overall, and implying expectations that are much stronger than what investors appear to be pricing into the typical biotech stock. See what the numbers say about this price — find out in our valuation breakdown. Result: Price-to-book of 17.6x (ABOUT RIGHT) However, there are clear pressure points, including Scholar Rock’s pre revenue status and a reported net loss of US$353.428 million, which could quickly challenge any bullish case. Find out about the key risks to this Scholar Rock Holding narrative. Another View: DCF Points to Deep Undervaluation While the 17.6x P/B suggests a rich price tag versus the wider biotech group, our DCF model provides a different perspective. It puts Scholar Rock’s fair value at about US$208.90 per share, versus the current US$42.18, which screens as roughly 79.8% below that estimate. If the P/B hints at a lot of optimism already in the price, and the DCF implies the market is being overly cautious, which signal do you put more weight on at this stage? Look into how the SWS DCF model arrives at its fair value. SRRK Discounted Cash Flow as at Jan 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Scholar Rock Holding for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 877 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own Scholar Rock Holding Narrative If you see the numbers differently or simply want to pressure test these assumptions against your own view, you can quickly build a personalised Scholar Rock story in a few minutes, starting with Do it your way. A great starting point for your Scholar Rock Holding research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision. Looking for more investment ideas? If you stop with one stock, you risk missing other opportunities that might fit your style even better, so keep pushing your research a step further.  Chase potential high reward setups by scanning these 3540 penny stocks with strong financials that pair tiny market caps with stronger financial footing than many expect. Position yourself early in powerful themes by checking these 28 AI penny stocks that sit at the crossroads of artificial intelligence and fast moving market trends. Hunt for possible mispricing with these 12 dividend stocks with yields > 3% that combine income potential above 3% with balance sheets that may support ongoing payouts.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602534345","isCrawlerRequest":true}